Factors influencing the duration of pregnancy termination with vaginal misoprostol for fetal abnormality

Prenatal Diagnosis

Volumn 29, Issue 5, 2008, Pages 520-524

  Dickinson, Jan E ^a,b   Doherty, Dorota A ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Women and Infants Research Foundation   (Australia)

Author keywords

Abortion; Duration; Fetal abnormality; Misoprostol

Indexed keywords

MISOPROSTOL;

ADOLESCENT; ADULT; ANEUPLOIDY; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; FEMALE; FETUS; FETUS DISEASE; GESTATIONAL AGE; HEART DISEASE; HUMAN; HUMAN EXPERIMENT; MATERNAL AGE; MEDICAL RECORD REVIEW; MUSCULOSKELETAL SYSTEM MALFORMATION; NEURAL TUBE DEFECT; PARITY; PREGNANCY TERMINATION; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, EUGENIC; ABORTION, MISSED; ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; COHORT STUDIES; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; MIDDLE AGED; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 66849115629     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2236     Document Type: Article

References (14)

1. Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM. 2004. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 69: 51-58.
2. Daponte A, Nzewenga G, Dimopoulos KD, Guidozzi F. 2006. The use of vaginal misoprostol for second trimester pregnancy termination in women with previous single cesarean section. Contraception 74: 324-327.
3. Daskalakis G, Mesogitis S, Papantoniou N, Moulopoulos G, Papa-panagiotou A, Antsaklis A. 2005. Misoprostol for second-trimester pregnancy termination in women with prior caesarean section. BJOG 111: 97-99.
4. Dickinson JE. 2005. Misoprostol for second trimester pregnancy termination in women with a prior cesarean delivery. Obstet Gynecol 105: 352-356.
5. Dickinson JE, Evans SF. 2002. The optimisation of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. Am J Obstet Gynecol 186: 470-474.
6. Dickinson JE, Evans SF. 2003. A comparison of oral with vaginal administration of misoprostol in second trimester termination for fetal anomaly. Obstet Gynecol 101: 1294-1299.
7. Dickinson JE, Godfrey M, Evans SF. 1998. The efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial. J Matern Fetal Med 7: 115-119.
8. Dodd JM, Crowther CA. 2006. Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: a systematic review. Eur Obstet Gynecol 115: 3-8.
9. Goh SE, Thong KJ. 2006. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases. Contraception 73: 516-519.
10. Hinshaw K, El-Refaey H, Rispin R, Templeton A. 1995. Mid- trimester termination for fetal abnormality: advantages of a new regimen using mifepristone and misoprostol. Br Obstet Gynaecol 101: 559-560.
11. Jannet D, Aflak N, Abankwa A, Carbonne B, Marpeau L, Milliez J. 1996. Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostol. Eur Obstet Gynecol Reprod Biol 70: 159-163.
12. Lalitkumar S, Bygdeman M, Gemzell-Danielsson K. 2007. Mid- trimester induced abortion: a review. Hum Reprod Update 13: 37-52.
13. Lo TK, Lau WL, Lai FK, et al. 2008. Effect of fetal diagnosis on the outcomes of second-trimester pregnancy termination for fetal abnormalities: a pilot study. Matern Fetal Neonat Med 11: 523-527.
14. Nesbitt D, Giles W. 1996. Prolonged induction to delivery time in termination of pregnancy using 16, 16-dimethyl- PGE1-methyl ester (gemeprost) for fetuses with a neural tube defect or hydrocephalus. Aust NZ Obstet Gynaecol 36: 300-303.